PDCD1 and gastric cancer: Nevertheless, a possible correlation between H. pylori and the effectiveness of PD-1/PD-L1 inhibitors has only been addressed in a limited number of studies, and to date there is no conclusive evidence on whether H. pylori can be considered as a predictive biomarker for response to immunotherapy in GC.